Cargando…
Clinical efficacy of anti-vascular endothelial growth factor versus panretinal photocoagulation for patients with proliferative diabetic retinopathy: A protocol for systematic review and meta-analysis
BACKGROUND: The argument on the optimal treatment for patients with proliferative diabetic retinopathy (PDR) remains to be resolved. Therefore, the primary objective of the present study was to evaluate the clinical efficacy of anti-vascular endothelial growth factor (anti-VEGF) therapy versus panre...
Autores principales: | Lin, Yuxian, Zheng, Xiaowei, Chen, QiuJie, Wu, Ruibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084044/ https://www.ncbi.nlm.nih.gov/pubmed/33907139 http://dx.doi.org/10.1097/MD.0000000000025682 |
Ejemplares similares
-
Clinical efficacy of intravitreal aflibercept injection versus vitrectomy with panretinal photocoagulation for patients with proliferative diabetic retinopathy: A protocol for systematic review and meta-analysis
por: Hu, Yao, et al.
Publicado: (2021) -
Clinical efficacy and acceptability of panretinal photocoagulation combined with conbercept for patients with proliferative diabetic retinopathy: A protocol for systematic review and meta-analysis
por: Wang, Liangyu, et al.
Publicado: (2021) -
Review of Studies Comparing Panretinal Photocoagulation and Anti-Vascular Endothelial Growth Factor Therapy in the Treatment of Proliferative Diabetic Retinopathy
por: Gunasekaran, Thiruvarasu, et al.
Publicado: (2022) -
Efficacy of conbercept combined with panretinal photocoagulation in the treatment of proliferative diabetic retinopathy
por: He, Feng, et al.
Publicado: (2020) -
Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy
por: Nicholson, Luke, et al.
Publicado: (2018)